Correction to: Cancer Gene Therapy https://doi.org/10.1038/s41417-019-0123-9, published online 18 July 2019
After publication an error was found in Table 3 of the manuscript in the columns related to gender distribution. After precise review and return to the source of the research and the collected papers, the following was found: Female (1a) = 10 (55.6%); Male (1a) = 8 (44.4%); Total N of (1a) = 18. Female (2) = 4 (20.0%); Male (2) = 16 (80.0%); Total N of (2) = 20. These modifications do not affect the results or the discussion of the manuscript, as age was not an influencing factor in this study or associated with any other parameters in the study. The amended figure accompanies this correction.
The original article has been corrected.
Change history
22 June 2022
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1038/s41417-022-00496-9
Author information
Authors and Affiliations
Corresponding author
Additional information
The article to which this update relates has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1038/s41417-022-00496-9
About this article
Cite this article
El-Araby, R.E., Khalifa, M.A., Zoheiry, M.M. et al. Correction: The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients. Cancer Gene Ther 29, 1297–1298 (2022). https://doi.org/10.1038/s41417-022-00440-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41417-022-00440-x
